Patented Medicine Prices Review Board releases August 2018 NEWSletter.

Consultation on the new MOPOP section is open until August 10, 2018.

The report of the Working Group will be presented to the PMPRB for consideration prior to the publication of draft Guidelines in the fall, followed by a further period of consultation.

Shares of Spherix Inc. soared on 6 March 2020 shortly after the company announced that it had executed an exclusive option agreement with the University of Maryland, ...

In its April 2019 NEWSletter, the Patented Medicine Prices Review Board (PMPRB) announced that the Steering Committee on Guidelines Modernization would hold its final meeting on May 13, 2019, to discuss both a draft report of its deliberations and the Working Group's final report

The World Intellectual Property Organization (the "WIPO") has launched an online resource for centralized monitoring of COVID-19 related measures...

On September 24, 2020, the Supreme Court of Canada denied leave to Apotex (Docket No. 39172) with respect to a decision affirming the quantum of profits payable to the Plaintiffs...

In view of the ongoing COVID-19 pandemic, the Canadian Intellectual Property Office (CIPO) has further extended patent, trademark, and industrial design deadlines fixed under the relevant legislation.

In response to the COVID-19 pandemic and subsequent to its announcement made on March 17, the Canadian Intellectual Property Office (CIPO) announced on March 27, 2020 to add to "designated days"...

CIHI: On December 17, the Canadian Institute for Health Information (CIHI) published statistics on drug spending, finding that in 2018, around 40% of drug spending was...

The Canadian Patent Office issued a practice note on June 20, 2006 stating that animals from any stage of development from fertilized eggs on are higher life forms and thus not patentable subject matter.

Health Canada has issued updated guidance reflecting the September 21, 2017 amendments: Guidance Document: Patented Medicines (Notice of Compliance) Regulations (see our summary of the amendments here).

On March 30, 2020, Kennedy and Janssen applied to the Supreme Court of Canada for leave to appeal a Federal Court of Appeal decision relating to Kennedy's patent covering uses of REMICADE...

For complete details about these proceedings, click here.

The amendments to the Regulations are expected to be effective as of July 1, 2020.

The September NEWSletter also provides information about the PMPRB’s participation in past and future events, as well as NPDUIS research initiative and activities.

We provided an update on biosimilars: Health Canada's guidance, approvals and reviews of biosimilars to date, the effect of CETA amendments to biologics, pending patent litigation...

MediaTube Corp v Bell Canada, 2017 FC 16 appears to provide a promising Canadian judgement that clarifies the assessment of the validity and infringement of an information technology patent with respect to the telecommunications industry.

Patricia Folkins, Reshika Dhir, and Coralee Ridder authored the article "At the Interfaces of Al, Chemistry and Patents - Opportunities and Challenges" published by Legal Industry Reviews.

L'office de la propriété intellectuelle du Canada a annoncé une augmentation significative des taxes, dès le 1er janvier 2024. Cette décision survient dans un contexte de déficit structurel...